Edition:
India

Eris Lifesciences Ltd (ERIS.NS)

ERIS.NS on National Stock Exchange of India

796.35INR
8 Dec 2017
Change (% chg)

Rs3.15 (+0.40%)
Prev Close
Rs793.20
Open
Rs785.15
Day's High
Rs814.00
Day's Low
Rs785.00
Volume
288,230
Avg. Vol
136,755
52-wk High
Rs833.80
52-wk Low
Rs510.00

Chart for

About

Eris Lifesciences Limited is an India-based company, which is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market. The Company operates within various areas through its seven focused divisions: Eris, Nikkos, Adura, Montana, Inspira, Victus and... (more)

Overall

Beta: --
Market Cap(Mil.): Rs80,238.13
Shares Outstanding(Mil.): 137.50
Dividend: --
Yield (%): --

Financials

BRIEF-India's Eris Lifesciences To Avail Loan Facility Worth 4 Bln Rupees From Axis Bank

* SAYS TO AVAIL TERM LOAN FACILITY WORTH 4 BILLION RUPEES FROM AXIS BANK LTD

01 Dec 2017

BUZZ-Strides, Eris rise on deal for India brand business

** Strides Shasun Ltd rises as much as 4.5 pct to its highest in almost a fortnight

20 Nov 2017

BRIEF-RBI says foreign investment limit in Eris Lifesciences increased to 49 pct

* Investment under PIS in Eris Lifesciences Ltd by FII/FPI investment limit up from 24 percent to 49 percent; increase in NRI limit from 10 to 24 percent ‍​ Source text: http://bit.ly/2w04o7W Further company coverage:

22 Aug 2017

BRIEF-India's Eris Lifesciences June-qtr consol profit rises

* June quarter consol net profit 708.4 million rupees versus 624.4 million rupees year ago

17 Aug 2017

Earnings vs. Estimates

No consensus analysis data available.